Expending the power of artificial intelligence in preclinical research: an overview

Artificial intelligence (AI) is described as the joint set of data entry, able to receive inputs, interpret and learn from such feedbacks, and display related and flexible independent actions that help the entity reach a specific aim over a period of time. By extending its health-care applications continuously, the ultimate AI target is to use machine simulation of human intelligence processes such as learning, reasoning, and self-correction, to mimic human behaviour. AI is extensively used in diverse sectors of medicine, including clinical trials, drug discovery and development, understanding of target-disease associations, disease prediction, imaging, and precision medicine. In this review, we firstly describe the limitations and challenges of the AI tools and techniques utilized in medicine, followed by current uses and applications of AI in the translational field, highlighting the cardio-renal preclinical models with potential to contribute to future clinical research.

[1]  Collin M. Stultz,et al.  A Deep Learning Model for Inferring Elevated Pulmonary Capillary Wedge Pressures From the 12-Lead Electrocardiogram , 2022, JACC: Advances.

[2]  D. Balvay,et al.  FIBER-ML, an open-source supervised machine learning tool for quantification of fibrosis in tissue sections. , 2022, The American journal of pathology.

[3]  M. Ijaz,et al.  Artificial intelligence in disease diagnosis: a systematic literature review, synthesizing framework and future research agenda , 2022, Journal of Ambient Intelligence and Humanized Computing.

[4]  S. Lee,et al.  Ultrasound deep learning for monitoring of flow-vessel dynamics in murine carotid artery. , 2021, Ultrasonics.

[5]  Vasanthanathan Poongavanam,et al.  Enhancing preclinical drug discovery with artificial intelligence. , 2021, Drug discovery today.

[6]  Erich S. Huang,et al.  Correction to: The role of machine learning in clinical research: transforming the future of evidence generation , 2021, Trials.

[7]  Jian Zheng,et al.  Diagnostic Test Accuracy of Deep Learning Detection of COVID-19: A Systematic Review and Meta-Analysis , 2021, Academic Radiology.

[8]  Emmette R. Hutchison,et al.  The role of machine learning in clinical research: transforming the future of evidence generation , 2021, Trials.

[9]  Vijaya B. Kolachalama,et al.  Machine Learning Applications in Nephrology: A Bibliometric Analysis Comparing Kidney Studies to Other Medicine Subspecialities , 2021, Kidney medicine.

[10]  Brandon G. Ginley,et al.  Automated detection and quantification of Wilms’ Tumor 1-positive cells in murine diabetic kidney disease , 2021, Medical Imaging.

[11]  P. Noseworthy,et al.  Artificial intelligence-enhanced electrocardiography in cardiovascular disease management , 2021, Nature Reviews Cardiology.

[12]  Sonali Karekar,et al.  Current status of clinical research using artificial intelligence techniques: A registry-based audit , 2021, Perspectives in clinical research.

[13]  A. Bhatt.  Artificial intelligence in managing clinical trial design and conduct: Man and machine still on the learning curve? , 2021, Perspectives in clinical research.

[14]  Sotiris Kotsiantis,et al.  Explainable AI: A Review of Machine Learning Interpretability Methods , 2020, Entropy.

[15]  K. Shockley,et al.  Using Artificial Intelligence to Detect, Classify, and Objectively Score Severity of Rodent Cardiomyopathy , 2020, Toxicologic pathology.

[16]  Peter Bankhead,et al.  Deep Learning-Based Segmentation and Quantification in Experimental Kidney Histopathology. , 2020, Journal of the American Society of Nephrology : JASN.

[17]  Dnyaneshwar Kalyane,et al.  Artificial intelligence in drug discovery and development , 2020, Drug Discovery Today.

[18]  Ephraim M Hanks,et al.  Machine learning for modeling animal movement , 2020, PloS one.

[19]  Yue Liu,et al.  An Innovative Method for Screening and Evaluating the Degree of Diabetic Retinopathy and Drug Treatment Based on Artificial Intelligence Algorithms. , 2020, Pharmacological research.

[20]  E. Topol,et al.  A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: a systematic review and meta-analysis. , 2019, The Lancet. Digital health.

[21]  Rabi Yacoub,et al.  Computational Segmentation and Classification of Diabetic Glomerulosclerosis. , 2019, Journal of the American Society of Nephrology : JASN.

[22]  Jianying Hu,et al.  Artificial Intelligence for Clinical Trial Design. , 2019, Trends in pharmacological sciences.

[23]  Michael Gadermayr,et al.  Iterative learning to make the most of unlabeled and quickly obtained labeled data in histology , 2018, MIDL.

[24]  Divya Jain,et al.  Feature selection and classification systems for chronic disease prediction: A review , 2018, Egyptian Informatics Journal.

[25]  Tong Liu,et al.  Segmentation of histological images and fibrosis identification with a convolutional neural network , 2018, Comput. Biol. Medicine.

[26]  Michael Gadermayr,et al.  Segmenting renal whole slide images virtually without training data , 2017, Comput. Biol. Medicine.

[27]  Rabi Yacoub,et al.  Multi-radial LBP Features as a Tool for Rapid Glomerular Detection and Assessment in Whole Slide Histopathology Images , 2017, Scientific Reports.

[28]  Michael Gadermayr,et al.  CNN Cascades for Segmenting Whole Slide Images of the Kidney , 2017, Comput. Medical Imaging Graph..

[29]  Haipeng Shen,et al.  Artificial intelligence in healthcare: past, present and future , 2017, Stroke and Vascular Neurology.

[30]  Erwan Scornet,et al.  A random forest guided tour , 2015, TEST.

[31]  Ying LU,et al.  Decision tree methods: applications for classification and prediction , 2015, Shanghai archives of psychiatry.

[32]  Mahmoud Fakhr,et al.  Diagnosis of Cardiovascular Diseases with Bayesian Classifiers , 2015, J. Comput. Sci..

[33]  Wesam M. Ashour,et al.  Initializing K-Means Clustering Algorithm using Statistical Information , 2011 .

[34]  Francisco Beneke,et al.  Artificial Intelligence and Collusion , 2018, IIC - International Review of Intellectual Property and Competition Law.

[35]  Wolfgang Dierking,et al.  Observing lake- and river-ice decay with SAR: advantages and limitations of the unsupervised k-means classification approach , 2013, Annals of Glaciology.

[36]  Igor V. Tetko,et al.  Data modelling with neural networks: Advantages and limitations , 1997, J. Comput. Aided Mol. Des..